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Abstract
Background: The association between exposure to secondhand smoke (SHS) during pregnancy and a child’s
neurodevelopment has not been established yet. We explored the association between prenatal exposure to SHS
and neurodevelopment at 24 months of age considering genetic polymorphism and breastfeeding in 720 mothers
and their offspring enrolled in the Korean multicenter birth cohort study (Mothers and Children Environmental
Health, MOCEH).
Methods: We quantified urine cotinine concentrations in mothers once from 12th to 20th gestational weeks and
excluded those whose urine cotinine levels exceeded 42.7 ng/ml to represent SHS exposure in early pregnancy.
Mental developmental index (MDI) and psychomotor developmental index (PDI) values were measured using the
Korean version of the Bayley Scales of Infant Development II (K-BSID-II) at 24 months of age. A general linear model
was used to assess the relationship between maternal urinary cotinine level and neurodevelopment.
Results: MDI scores were inversely associated with cotinine [β=− 2.73; 95% confidence interval (CI): − 5.32 to − 0.15] in
children whose mothers had early pregnancy urinary cotinine levels >1.90 ng/ml. No association was evident in children
whose mothers had cotinine levels ≤1.90 ng/ml. This negative association was more pronounced in children whose
mothers had both Glutathione S-transferases mu 1 (GSTM1) and theta 1 (GSTT1) null type [β=− 5.78; 95% CI: -10.69 to − 0.
87], but not in children whose mothers had any present type of GSTM1/GSTT1 [β=− 1.64; 95% CI: -4.79 to 1.52]. The
association was no longer significant when children received breast milk exclusively for up to 6months [β=− 0.24; 95% CI:
-4.69 to 4.20] compared to others [β=− 3.75; 95% CI: -7.51 to 0.00]. No significant association was found for PDI.
Conclusions: Maternal exposure to SHS during pregnancy may result in delayed MDI in early childhood. This effect might
be modified by genetic polymorphism and breastfeeding behavior.
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Background
Exposure to active smoking and secondhand smoke (SHS)
causes health concern. About 40% of children, 35% of
women, and 33% of men are exposed to SHS in their daily
lives [1]. World Health Organization (WHO) has recently
reported that environmental risks including SHS take lives
of 1.7 million children under 5 years of age every year [2].
Harmful exposure to these environmental risks could
begin in the mother’s womb and affect fetal development.
Therefore, more attention should be paid to pregnant
women and infants who are susceptible to SHS exposure.
It is well known that SHS exposure brings about al-
most the same adverse health outcomes as active smok-
ing [3]. Smoking during pregnancy is a well-known risk
factor for adverse birth outcomes such as spontaneous
abortion [4], low birth weight, and preterm birth [5]
that, in turn might affect children’s development. To-
bacco smoke contains over 7000 chemicals including
nicotine, polycyclic aromatic hydrocarbons (PAHs), aro-
matic amines, and carbon monoxide. Placental passage
of these environmental toxicants might affect prenatal
nervous system development. Although effects of pre-
natal exposure to SHS on early neurodevelopment vary
among studies, they remain significant issues. Lower de-
velopment scores in cognition, language, and fine motor
scales [6, 7], gross motor scores [8], and MDI scores [9]
have been reported in children with prenatal SHS expos-
ure. Therefore, SHS exposure should be considered a
modifiable risk factor for delayed neurodevelopment and
cognitive impairment in children. As cotinine is a pre-
dominant metabolite of nicotine, it is considered a bio-
marker of exposure to SHS [10]. Cotinine assays provide
an objective quantitative measure that is more reliable
than smoking history or counting the number of ciga-
rettes smoked per day. Measure of cotinine in hair,
blood, and urine permits the assessment of SHS expos-
ure or active smoking.
Metabolic gene polymorphisms might modify the
effect of toxins on the outcome of pregnancy and
development afterwards. Glutathione S-transferases
mu 1 (GSTM1) and theta 1 (GSTT1) are major de-
toxification phase II enzymes that provide critical
defense against xenobiotics. Numerous smoke-de-
rived chemicals such as PAHs and aromatic amines
can be detoxified by GSTM1. Metabolites of 1,3-bu-
tadiene and ethylene oxide present in tobacco smoke
are detoxified by GSTT1 [11]. Homozygous deletion
polymorphisms of GSTM1 and GSTT1 (GSTM1-null
and GSTT1-null) can result in loss of function and
increase the risk of faulty fetal development [12].
GSTM1/GSTT1 polymorphisms can significantly modify
birth outcomes following maternal exposure to tobacco
smoke [13–16], heavy metals [17], perfluorinated com-
pounds [18], and particulate matter [19]. These
polymorphisms also influence early neurodevelopment of
infants born following maternal exposure to environmen-
tal tobacco smoke [6].
Breastfeeding is thought to be associated with better
neurodevelopment. It is well known that breastfeeding
provides nutritional and immunological benefits to in-
fants and promotes cognitive development between the
mother and the infant [20–22]. Improved cognitive de-
velopment of infants who are breastfed longer has been
described elsewhere [23]. Benefits of breastfeeding even
extend to mothers who are current smokers [24].
Although the Korean government has established sev-
eral public policies since 1995, 39.7% of non-smokers
are still exposed to SHS. This percentage is higher than
that in other countries. In addition, 18.5% of pregnant
women responded affirmatively to SHS exposure in
Korea [25]. Although concern about the effect of SHS
on health has been increasing, very few researches have
been conducted using Korean population.
Therefore, the aim of this study was to investigate the
association between prenatal SHS exposure and neuro-
development of infants 24 months after birth using Ko-
rean birth cohort study. We further identified whether
the association could be modified by maternal genetic
polymorphisms and breastfeeding behavior.
Methods
Study population
Data were from the Mothers and Children’s Environmental
Health (MOCEH) study, a multicenter prospective cohort
study initiated since 2006 in Korea. This study was designed
to collect information related to environmental exposures
during pregnancy and childhood to examine how exposure
to environmental pollutants might affect growth, develop-
ment, and disease in South Korea. Detailed information of
the MOCEH study has been described previously [26]. Preg-
nant women in their first trimester were recruited from three
university hospitals located in Seoul (metropolitan area),
Cheonan (urban area, midwest), and Ulsan (metropolitan
and industrial area, southeast) between 2006 and 2010. Par-
ticipants were > 18 years of age. A total of 1751 pregnant
women were enrolled in the beginning and 1516
mother-child pairs were followed up after birth (Fig. 1). Our
study subjects were restricted to 801 children whose mater-
nal urinary cotinine levels were determined between 12th
and 20th gestational weeks. They also completed a neurode-
velopmental follow-up assessment using Bayley tests at 24
months of age. There were no significant differences between
children with Bayley scores (n= 801) and those without Bay-
ley scores (n= 630) at 24months with respect to maternal
age, mother’s education level, genetic polymorphisms, sex of
children, or breastfeeding behavior except for residential area
and the primary caregiver up to 24months after birth (Add-
itional file 1: Table S1). Children (n= 53) were excluded if
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they were born with low birth weight (birth weight < 2500 g),
preterm (gestational age < 37weeks), or diagnosed with
intrauterine growth restriction at birth. Written informed
consent was obtained at the initial visit from all enrolled
mothers on behalf of themselves and their children. Study
protocols were approved by Institutional Review Boards of
Ewha Womans University (Seoul), Dankook University
Hospital (Cheonan), and Ulsan University Hospital (Ulsan).
Measurement of urine cotinine levels
Cotinine is considered a good biomarker of tobacco-smoke
exposure. Urine can be obtained easily and non-invasively
from pregnant women. Thus SHS exposure during preg-
nancy was quantified using urinary cotinine level in this
study. Maternal urine was sampled once from 12th to 20th
gestational weeks. Cotinine Direct ELISA Kits (Calibiotech,
Spring Valley, CA, USA) were used for determinations. Urine
was diluted 1:100 and 10 μl of the diluted sample was applied
in duplicates to 96-well microtiter plates. Diluted urine sam-
ple was incubated with 100 μl of enzyme conjugate at room
temperature for 60min. Wells were washed six times with
300 μl distilled water prior to addition of 100 μl of substrate
reagent to each well. Plates were then incubated at room
temperature for 30min. Absorbance was measured at 450
nm on an ELISA reader within 15min after adding 100 μl of
Stop Solution. Limit of detection (LOD) for urinary cotinine
was 1.0 ng/ml. Values below this limit were converted to
non-negative values by half of the detection limit (LOD/2) in
the analysis. Urinary creatinine levels were adjusted in our
analyses.
Assessment of infants’ MDI and PDI at 24months
Neurodevelopment of infant at 24months of age was mea-
sured using the Korean version of Bayley Scale of Infant De-
velopment II (K-BSID-II) [27], a standardized tool for
assessing infant neurodevelopment [28]. This produces de-
velopmental indices and composite scores to compare devel-
opmental performance of a child with norms taken from
typically developing Korean children of the same age.
K-BSID-II also assesses habituation, problem solving, mem-
ory, classification, vocalization, and language skills. The
resulting score represents mental development index (MDI).
Psychomotor development index (PDI) is scored for the de-
gree of body control, muscle coordination, postural control,
and finer manipulatory skills. K-BSID-II has shown excellent
test-retest stability and inter-rater agreement [27]. Test score
was standardized, having a mean of 100 and a standard devi-
ation of 15 [29]. To increase the inter-rater consistency, an-
nual rater training sessions with video monitoring were held
(inter-rater consistency: kappa value > 0.8) [30].
Genotyping of GSTM1 and GSTT1
Genomic DNA was extracted from maternal whole blood
using a QIAamp DNA blood kit (Qiagen, Valencia, CA,
USA). Polymerase chain reaction (PCR) was used to geno-
type GSTM1 and GSTT1 polymorphisms. As a positive
control, a 268-bp fragment of β-globin gene was amplified
at the same time. PCR mixture (20 μl) for GSTM1 and
GSTT1 genotyping contained 10mM Tris-HCl (pH 9.0),
40mM KCl, 1.5 mM MgCl2, 0.25mM of each dNTP, 1
unit Taq polymerase (Bioneer, Seoul, Korea), 20 pmol of
forward and reverse primers each, and 50–100 ng of the
Fig. 1 Flowchart showing the selection of the study population at 24 months (n = 720)
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genomic DNA as a template. The following primer sets of
GSTM1 and GSTT1 genes were used for PCR reaction:
5′-GAACTCCCTGAAAAGCTAAAGC-3′ (forward) and
5′-GTTGGGCTCAAATATACGGTGG-3′ (reverse) for
GSTM1, and 5′-TCACCGGATCATGGCCAGCA-3′ (for-
ward) and 5′-TTCCTTACTGGTCCTCACATCTC-3′ (re-
verse) for GSTT1. Amplifications were performed using an
initial denaturation at 94 °C for 5min; 35 cycles of denatur-
ation at 94 °C for 1min, annealing at 65 °C for 1min, and ex-
tension at 72 °C for 1min; and a final extension at 72 °C for
7min. PCR amplification of the reaction mixture was carried
with a PTC-200 thermal cycler (MJ Research, Watertown,
MA, USA).
To evaluate PCR-amplified fragments, electrophoresis
was performed using 3% 3:1 NuSieve/agarose gel (Cam-
brex Bio Science, Rockland, ME, USA). Genotyping of
GSTM1 and GSTT1 genes was performed based on the
presence of a 215-bp product and a 459-bp product, re-
spectively. Null genotype was defined as a homozygous
deletion of the gene. To confirm results of analyses, 10%
of samples were randomly selected and genotyped again,
with identical results.
Covariates
Potential confounders were selected through literature
review. Sociodemographic data including maternal age,
maternal education level, and region were reported in
the baseline questionnaire at the first visit. Each variable
was considered as a categorical variable: ≤ 30 years old
or > 30 years old for maternal age; ≤ high school or ≥
university for maternal education; and Seoul, Cheonan,
and Ulsan for region. Information of infant sex as a cat-
egorical variable and gestational age as a continuous
variable was obtained at delivery. At 6-month follow-up,
mothers were asked about how they were feeding their
babies. We categorized children into two groups: breast-
feeding only for up to 6months as exclusive breastfeed-
ing or others. We also defined the primary caregiver
during the first 24 months after birth based on the ques-
tionnaire at each follow-up: mother during the whole
period or others.
Statistical analyses
First, we conducted receiver operating characteristic (ROC)
curve analysis [31] to obtain the optimal cut-off point of
urinary cotinine levels for distinguishing active smokers
from non-active smokers during pregnancy. Based on our
database, active smoker was defined as a mother who
responded positively to a question, ‘Do you smoke now?’ in
early or mid-pregnancy. Everyone else was considered a
non-active smoker. ROC analysis is a graphical and quanti-
tative technique that can determine the optimal cut-off
point for a classified decision for a given continuous criter-
ion variable. Here, the criterion variable is urinary cotinine.
The classified condition is self-reported smoking status dur-
ing pregnancy. Sensitivity is the percentage of smokers ex-
ceeding the cut-off point and specificity represents the
percentage of nonsmokers below the cut-off point.
Characteristics of the study population are presented
as mean ± standard deviation (SD) for continuous vari-
ables or numbers and percentages for categorical vari-
ables. Difference was compared using Chi-squared test
or t-test. Maternal urinary cotinine level was natural log
(ln)-transformed in all analyses because of its skewed
distribution. Summary statistics for urinary cotinine level
(including arithmetic and geometric means, and percen-
tiles) were calculated.
Generalized additive model (GAM) [32] was used to
examine the non-linear association between maternal
urinary cotinine level at early pregnancy and offspring’s
K-BSID-II test score at 24 months. Based on results from
GAM analysis, children were divided into two groups
according to their mothers’ urinary cotinine levels: above
or below the median (1.90 ng/ml). For each group, asso-
ciations between maternal urinary cotinine levels and
offspring’s K-BSID-II test scores were separately assessed
using a multiple linear regression model after adjusting
for ln-transformed urinary creatinine level, sex of a
child, maternal age, maternal education, gestational age,
region, breastfeeding up to 6 months, and primary care-
giver during the first 24 months after birth. Data were
further analyzed after data stratification by maternal
genetic polymorphisms or breastfeeding to investigate
their modification effect on the association. Maternal
GSTM1/GSTT1 genotype was classified as any present
or both null. We then tested the significance of inter-
action term between maternal urinary cotinine level at
early pregnancy and each stratum.
A supplementary analysis was conducted to examine
the robustness of results. We repeated all analyses with-
out adjusting for urinary creatinine because using urine
cotinine values not corrected for urine creatinine values
showed high correlation with smoking behavior [33]. All
analyses were considered to be statistically significant if
p-values were less than 0.05. All data preparation and
analyses were performed using SAS statistical package,
version 9.4 (SAS Institute Inc., Cary NC, USA).
Results
From ROC curve analysis, the optimal cut-off level for
discriminating active smokers from non-smokers during
pregnancy was 42.7 ng/ml, with a sensitivity of 81.8%, a
specificity of 96.5%, and an area under the curve of 0.91
(Fig. 2). We then further excluded 28 children whose
mothers were considered as active smokers because their
urine cotinine levels exceeded 42.7 ng/ml. Finally, 720
mother-child pairs were included in the our analyses.
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Demographic characteristics of study participants are pre-
sented in Table 1. Sixty percent of the women were ≤ 30
years old and 51.7% had at least a university education. MDI
scores at 24months were significantly higher in children
with younger mothers. MDI and PDI scores at 24months
varied significantly according to mother’s education level and
region. Girls displayed significantly higher scores of MDI and
PDI at 24months than boys. The median of maternal urin-
ary cotinine level assessed at early pregnancy was 1.90 ng/ml.
Figure 3 presents a nonlinear relationship between
ln-transformed maternal urinary cotinine level and resi-
dualized unadjusted MDI and PDI scores. Concerning
MDI, no association was evident for lower level of urin-
ary cotinine, although a negative association was ob-
served for higher level of urinary cotinine (Fig. 3 (a)).
Therefore, we divided our data into two cohorts and an-
alyzed separately. One cohort included children whose
maternal urinary cotinine levels at early pregnancy were
at or below the median and the other cohort included
children whose maternal urinary cotinine levels at early
pregnancy were above the median. However, this pattern
was not observed for PDI (Fig. 3 (b)).
MDI scores of infants at 24 months of age and mater-
nal urinary cotinine levels during early pregnancy were
negatively associated if maternal urinary cotinine level
exceeded the median (β = − 2.73, 95% CI: -5.32 to − 0.15
from adjusted analysis) (Table 2). However, such nega-
tive association between infant’s PDI score at 24 months
and maternal urinary cotinine level disappeared. No as-
sociation was found when maternal urinary cotinine
level in early pregnancy was lower than the median.
The effect of maternal urinary cotinine level at early preg-
nancy on infant’s MDI score at 24months of age differed de-
pending on genetic polymorphism and breastfeeding
behavior (Additional file 1: Figure S1). The observed signifi-
cant negative association from Table 2 became much stron-
ger for infants whose mothers had GSTM1/GSTT1 double
deletion (β=− 5.78, 95% CI: -10.69 to − 0.87) (Table 3). The
significance of this negative association disappeared in in-
fants whose mothers had high cotinine levels when infants
received breastmilk exclusively up to 6months of age (β=−
0.24, 95% CI: -4.69 to 4.20). However, we found that none of
the interaction terms between urinary cotinine level and each
stratum was statistically significant.
These results did not change substantially when we
conducted analyses without adjusting for urinary cre-
atinine level (Additional file 1: Tables S2 and S3).
Discussion
We explored the association between maternal SHS ex-
posure during early pregnancy and infant neurodevelop-
ment at 24 months of age. We also examined the effect
of genetic polymorphism and exclusive breastfeeding on
such association. A significant association was found in
children whose mothers had higher (greater than me-
dian) levels of cotinine. Cognitive development of 24
months old infants decreased significantly with increas-
ing maternal cotinine level. For mothers with both
GSTM1 and GSTT1 null types, the negative association
became stronger. An association between PDI of 24
months old infants and maternal SHS exposure early in
the pregnancy was not evident.
Previous studies have investigated the impact of prenatal
maternal SHS exposure on infants’ neurodevelopment. Sec-
ondhand smoke exposure during pregnancy could be mea-
sured by parental self-reports or biomarkers such as
cotinine in cord blood and cotinine in maternal urine dur-
ing pregnancy. Based on self-reported prenatal exposure to
SHS, previous studies have shown a negative impact of
such exposure on cognitive development of infants aged 6–
36months [9, 34, 35]. Such negative association has also
been observed by using cord blood cotinine level [6] and
cotinine level in saliva during pregnancy [7]. We showed a
consistent result using urinary cotinine as a biomarker of
SHS exposure. A recent study has shown that maternal ex-
posure to SHS during pregnancy measured through urine
cotinine is associated with a decrease in gross motor func-
tion among children 18months old [8]. However, no asso-
ciation was found for the impact of SHS exposure on
cognitive function [8].
The biological mechanism by which SHS influences
neurodevelopment delay has not been established yet.
Huizink et al. [36] have provided potential mechanisms
to explain the association between prenatal exposure to
maternal smoking and neurobehavioral and cognitive
Fig. 2 ROC curve analysis of urinary cotinine levels for differentiating
current smokers from nonsmokers. The optimal urine cotinine cut-
off level to distinguish active smokers from non-active smokers was
42.7 ng/ml, with sensitivity of 81.8% and specificity of 96.5%. The
area under the curve (AUC) was 0.91
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outcomes based on animal and human studies. Results
using rodent exposure models have suggested that pre-
natal nicotine exposure during critical periods of devel-
opment can disrupt corticothalamic circuitry, resulting
in long-lasting dysregulation of sensory information
procession in the cortex [37]. A recent review study has
concluded that the effect of SHS is consistent with the
effect of direct smoking during pregnancy [3]. During
the embryonic and fetal period, the development of cen-
tral nervous system is vulnerable to toxic chemicals. Ex-
posure to such chemicals might not only have
short-term deficit, but also have long-term implications.
Cigarette smoke contains thousands of noxious com-
pounds, including mutagenic, neurotoxic, and fetotoxic






Mean ± SD P Mean ± SD P
Total 720 97.01 ± 14.52 96.78 ± 13.50
Maternal characteristics
Maternal age, years
≤30 429 (59.6) <0.001 98.28 ± 14.45 0.004 97.00 ± 13.57 0.59
>30 291 (40.4) 95.13 ± 14.44 96.45 ± 13.42
Maternal education
≤High school 284 (39.4) <0.001 95.23 ± 14.60 0.03 94.64 ± 13.74 0.002
≥University 372 (51.7) 98.16 ± 14.40 98.04 ± 13.31
missing 64 (8.9) 98.25 ± 14.27 98.97 ± 12.42
Region
Seoul 177 (24.6) <0.001 95.51 ± 14.43 0.02 97.97 ± 13.03 <0.001
Cheonan 340 (47.2) 96.34 ± 15.20 93.53 ± 12.84
Ulsan 203 (28.2) 99.44 ± 13.14 101.19 ± 13.63
GSTM1
Present (=positive) 315 (44.4) 0.003 96.19 ± 14.10 0.22 95.88 ± 12.66 0.12
Null (=negative) 394 (55.6) 97.53 ± 14.92 97.47 ± 14.20
GSTT1
Present (=positive) 345 (48.7) 0.48 96.32 ± 14.50 0.28 96.30 ± 13.25 0.38
Null (=negative) 364 (51.3) 97.51 ± 14.62 97.20 ± 13.84
Urinary cotinine
≤mediana 368 (50.6) 0.74 97.05 ± 14.81 0.80 96.86 ± 14.07 0.80
>mediana 359 (49.4) 96.77 ± 14.43 96.60 ± 12.97
Infant characteristics
Infant sex
Male 381 (52.9) 0.12 92.56 ± 14.31 <0.001 94.81 ± 13.45 <0.001
Female 339 (47.1) 102.01 ± 13.07 99.00 ± 13.23
Breastfeeding only up to 6 months
Yes 257 (35.7) <0.001 98.81 ± 14.40 0.04 97.33 ± 14.30 0.11
No 383 (59.2) 95.87 ± 14.55 95.93 ± 13.04
missing 80 (11.1) 96.68 ± 14.37 99.11 ± 12.81
Primary caregiver during the first 24 months after birth
Mother 368 (51.1) 0.55 97.90 ± 14.42 0.09 96.49 ± 13.99 0.56
Others 352 (48.9) 96.08 ± 14.58 97.09 ± 12.98
Gestational Age 39.06 ± 1.08
SD standard deviation, MDI Mental Development Index, PDI Psychomotor Development Index, GSTM1 Glutathione S-transferases mu1, GSTT1 Glutathione S-
transferases theta 1
aMedian of urinary cotinine level is 1.90 ng/ml
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agents such as nicotine, PAHs, aromatic amines, and
carbon monoxide. They could pass through the placenta
into the fetus [38–40]. These agents could cause fetal
hypoxia-ischemia by reducing utero-placental blood
flow. They might also influence fetal brain development
[9]. Although cognition and motor function are known
to be related to each other as the prefrontal cortex and
the cerebellum may play an important role in both [41],
our study demonstrated that infant’s MDI score rather
than PDI score at 24 months of ages was affected by ma-
ternal SHS exposure.
Phase I and phase II metabolic enzymes are important
in biotransformation of toxicants. GSTs consist of a
superfamily of dimeric phase II metabolic enzymes that
catalyze the conjugation of reduced glutathione with
various electrophilic compounds [42]. Since GST en-
zymes play a vital role in cellular defense against envir-
onmentally toxic compounds, polymorphisms of GST
gene can increase susceptibility to diseases caused by
chemicals such as those in cigarettes. Therefore, the ef-
fect of prenatal SHS exposure on pregnancy outcomes
can differ by maternal metabolic gene polymorphisms.
Several studies have reported significant gene modifica-
tion effects of maternal smoking or SHS exposure on
birth outcomes [14–16, 43, 44]. Hsieh et al. [6] have re-
ported that metabolic genes, GSTT1, as well as cyto-
chrome P450 1A1 (CYP1A1) Ile462Val can modify the
effect of cord blood cotinine level on early child neuro-
development, especially for language and fine motor de-
velopment using a small number of study subjects. Our
Fig. 3 Unadjusted associations of ln-transformed maternal urinary cotinine levels and Bayley scores in infants at 24 months of age. a Mental
Development Index (MDI) and (b) Psychomotor Development index (PDI). The Generalized Additive Model was used. Dashed vertical straight line
at 0.64 in each figure represents the median level of urinary cotinine, exp. (0.64) = 1.90
Table 2 Association between maternal urine cotinine in early pregnancy and children’s neurodevelopment at 24 months
Cotinine Bayley n Mean ± SD Unadjusteda Adjustedb
β 95% C.I. P β 95% C.I. P
≤ 1.90 MDI 368 97.05 ± 14.81 1.41 (−1.57, 4.38) 0.35 1.31 (−1.52, 4.14) 0.36
PDI 368 96.86 ± 14.07 1.63 (−1.20, 4.46) 0.26 1.88 (−0.90, 4.66) 0.19
> 1.90 MDI 352 96.97 ± 14.24 −1.79 (−4.29, −0.71) 0.16 −2.73 (−5.32, − 0.15) 0.04
PDI 352 96.70 ± 12.89 −0.60 (−2.87, 1.67) 0.61 − 0.35 (−2.69, 2.00) 0.77
aGeneral Linear Model adjusted for creatinine
bGeneral Linear Model adjusted for maternal age, maternal education, gestational age, infant sex, region, breastfeeding behavior, primary caregiver, and creatinine
MDI Mental Development Index, PDI Psychomotor Development Index
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present study in Korea with more participants using ma-
ternal urinary cotinine level in early pregnancy also pro-
vided evidence that metabolic genetic polymorphisms
had modifying effect on the association between mater-
nal SHS exposure in early pregnancy and neurodevelop-
ment scores at 24 months. The proportion of double
deletion of GSTM1 and GSTT1 observed in the Korean
population has been found to be higher than that observed
in Caucasian population, South Indians, or Afro-Americans
[42]. Therefore, our study suggests the importance of consid-
ering maternal genetic polymorphisms when counseling
about mother and their offspring’s health.
Breastfeeding up to 6 months is recommended by WHO
because it has several health benefits [45]. It can protect
against many diseases and medical conditions. It is also
beneficial for the child’s development and behavior [46]. A
specific examination of the relationship between breastfeed-
ing and childhood cognition has revealed that children who
are exclusively breastfed for the first 6months have higher
scores in Peabody Picture Vocabulary Test and Kaufman
Brief Intelligence Test at 3 and 7 years of age than those not
exclusively breastfed [47]. Some studies have suggested
that the effect of breastfeeding on child neurodeve-
lopment has to be investigated after adjusting for im-
portant confounders [48]. After controlling for some
primary confounders such as maternal education level
and primary caregiver during the first 24 months after
birth, our study showed that the negative impact of
SHS exposure at early pregnancy on MDI score at 24
months of age was diluted when children received
breast milk exclusively for 6 months after birth.
We restricted mothers whose urine cotinine levels were ≤
42.7 ng/ml and regarded them as non-active smokers be-
cause we focused on the effect of SHS exposure during preg-
nancy. There has been no standardized cut-off level of
urinary cotinine to distinguish active smokers from
non-active smokers. Several studies have suggested cut-off
levels ranging from 50 to 550 ng/ml [49, 50]. These cut-off
levels vary by race [51]. When we repeated analyses in all
mothers without excluding mothers with high urinary cotin-
ine levels, results were consistent (data not shown).
Previous studies have defined prenatal SHS exposed in-
fants as those with cord blood cotinine level ≥ 0.16 ng/ml [6]
or with maternal cotinine level in saliva during pregnancy
≥1.5 ng/ml [7]. Negative association was found between SHS
exposure and early neurodevelopment of infants up to 24
months of age in the exposed group [6]. A negative associ-
ation was also found in our study among women whose
urinary cotinine levels exceeded the median of 1.90 ng/ml.
However, further research is necessary concerning the
threshold cotinine level in urine, saliva, or cord blood that af-
fects neurodevelopment of infants.
The main strength of this study was its prospective co-
hort design with data collected from early pregnancy. We
were able to study prenatal exposure in relation to chil-
dren’s neurodevelopment. This prospective design enabled
us to control for various potential epidemiological biases.
Second, SHS exposure was not based on self-reported sur-
veys. Instead, it was assessed using urinary cotinine as a
biomarker. The use of self-reported SHS exposure might
result in biased estimates because of recall bias. Several
studies have described the advantage of using biomarkers
Table 3 Association between maternal urine cotinine in early pregnancy and children’s neurodevelopment at 24 months stratified
by genetic polymorphism and breastfeeding behavior
Cotinine ≤ 1.90a > 1.90a
n βb 95% C.I. P Pinteraction
d n βb 95% C.I. P Pinteraction
d
MDI GSTM1/GSTT1
Any present 241 2.51 (−1.14, 6.16) 0.18 0.25 251 − 1.64 (−4.79, 1.52) 0.31 0.16
Both null 119 −0.40 (−5.53, 4.74) 0.88 98 −5.78 (−10.69, − 0.87) 0.02
Breastfeeding only up to 6 months3
Yes 135 0.35 (−4.38, 5.09) 0.88 0.38 122 −0.24 (−4.69, 4.20) 0.91 0.22
No 195 2.31 (−1.94, 6.56) 0.29 188 −3.75 (−7.51, 0.00) 0.05
PDI GSTM1/GSTT1
Any present 241 2.45 (−1.07, 5.98) 0.17 0.83 251 −0.42 (−3.35, 2.51) 0.78 0.87
Both null 119 2.26 (−2.95, 7.46) 0.39 98 −1.25 (−5.64, 3.14) 0.57
Breastfeeding only up to 6 monthsc
Yes 135 −0.70 (−5.86, 4.46) 0.79 0.16 122 0.86 (−3.55, 5.27) 0.70 0.23
No 195 3.29 (−0.51, 7.09) 0.09 188 −0.70 (−3.96, 2.56) 0.67
amedian of urinary cotinine level = 1.90 (ng/ml)
bGeneral Linear Model adjusted for maternal age, maternal education, gestational age, infant sex, region, breastfeeding behavior, primary caregiver, and creatinine
cGeneral Linear Model adjusted for maternal age, maternal education, gestational age, infant sex, region, primary caregiver, and creatinine
dP-value for interaction
MDI Mental Development Index, PDI Psychomotor Development Index, GSTM1 Glutathione S-transferases mu1, GSTT1: Glutathione S-transferases theta 1
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for the assessment of SHS exposure compared to the use
of self-reporting [52–54].
This study also has several limitations. Exposure to SHS
reflects urinary cotinine level for a short time. The level of
urine cotinine is associated with the amount of exposure to
SHS. However, we used a single measurement of urinary co-
tinine level for the whole pregnancy which might not provide
an accurate estimate of the exposure. Serial measurements
of urinary cotinine throughout pregnancy are needed in fu-
ture studies. Second, we did not include possible confound-
ing factors such as quality of the home environment and
ventilation in our analyses. Instead, we adjusted for maternal
education as a surrogate marker. Third, numerous chemical
compounds in SHS were activated and detoxified by both
phase I and phase II enzymes. However, we could not inves-
tigate the role of other genes except GSTs due to the lack of
such information in our database. Fourth, although we con-
sidered certain substantial confounders in our analyses, the
effect of other environmental neurotoxins was not adjusted
in our analysis. Further study is needed to investigate
co-exposure of SHS and other environmental factors. Fifth,
human neurodevelopment continues after birth. However,
we did not consider the whole effect of postnatal exposure
that could affect children’s neurodevelopment after birth ex-
cept for breastfeeding behavior up to 6months and primary
caregiver up to 2 years of age. We showed that prenatal ex-
posure to SHS with high urinary cotinine level at early preg-
nancy was negatively associated with neurodevelopment
delay at 24months, proposing that early pregnancy might be
a critical window of public health intervention to reduce the
effect. Fetal development is highly likely to be susceptible to
environmental factors during the prenatal period. Thus, fur-
ther analysis is needed to understand the overall association
between exposure to SHS (including postnatal exposure) and
children’s neurodevelopment.
Conclusion
Exposure to maternal SHS during early pregnancy, espe-
cially in those who have high cotinine levels, may affect
neurodevelopment of infants at 24 months of age. Gen-
etic polymorphism and breastfeeding may modify the ef-
fect of SHS exposure on neurodevelopment.
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